DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

NCT03237325 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
Oral Mucositis

Interventions

DRUG: SGX942
DRUG: Placebo

Sponsor

Soligenix